Log in to search using one of your social media accounts:

 

Lyrica vs. Gabapentin: Differences between Pain Relief and Uses
Title: Lyrica vs. Gabapentin: Differences between Pain Relief and UsesCategory: MedicationsCreated: 10/31/2017 12:00:00 AMLast Editorial Review: 10/31/2017 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - October 31, 2017 Category: Endocrinology Source Type: news

Lyrica vs. Gabapentin: Which Is Better for Pain?
Title: Lyrica vs. Gabapentin: Which Is Better for Pain?Category: MedicationsCreated: 10/31/2017 12:00:00 AMLast Editorial Review: 10/31/2017 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - October 31, 2017 Category: Endocrinology Source Type: news

Literature Review Shows Options for Neuropathy in Long-Term Care
The literature has imperfect but important messages for long-term care regarding neuropathic pain management: the long-term care population “can still benefit from careful opioid prescribing,” that nonpharmacologic therapies have a role, and that among the non-opioid pharmacologic options “gabapentin, pregabalin, venlafaxine, and duloxetine have the best evidence for benefit.” (Source: Caring for the Ages)
Source: Caring for the Ages - October 28, 2017 Category: Health Management Authors: Christine Kilgore Source Type: news

Lyrica CR (Pregabalin Extended-Release Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions
October 12, 2017 - Pfizer Inc. (NYSE: PFE) announced today that the United States Food and Drug Administration (FDA) has approved Lyrica CR (pregabalin) extended-release tablets CV as once-daily therapy for the management of neuropathic pain... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 12, 2017 Category: Drugs & Pharmacology Source Type: news

Pregabalin: Spending on 'new valium' greater in north
A charity says prescribers of pregabalin need to be vigilant about a drug that was linked to 111 deaths in a year. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 11, 2017 Category: Consumer Health News Source Type: news

Alarming pregabalin abuse in Munich: prevalence, patterns of use and complications - Zellner N, Eyer F, Zellner T.
Background  Pregabalin is used e. g. for the treatment of neuropathic pain and anxiety disorder. Recently, its potential for abuse and addiction has become apparent. Methods From 2008 - 2015, we searched our database for the term "Pregabalin", inc... (Source: SafetyLit)
Source: SafetyLit - September 28, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Have you been affected by the misuse of Pregabalin in the UK?
The misuse of Pregabalin, a drug used to treat anxiety and epilepsy has been linked to a rise in the number of deaths. Share your experiencesA growing number of deaths have been linked to the misuse of Pregabalin, a drug used to treat pain, anxiety and epilepsy. In 2012 there were four deaths linked to it and last year this rose to a 111.It comes after claims that the drug has flooded the black market and is being sold illegally to addicts who mix it with other drugs, such as heroin. This can increase the risk of heart failure.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 14, 2017 Category: Science Authors: Sarah Marsh and Guardian readers Tags: Drugs Source Type: news

Prescription drug pregabalin linked to death rise
A BBC investigation has seen first-hand of the devastating impact of the prescription drug pregabalin which has 'flooded' the black market. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 11, 2017 Category: Consumer Health News Source Type: news

A systematic review of the effectiveness of policies restricting access to pregabalin - Stacey BR, Liss J, Behar R, Sadosky A, Parsons B, Masters ET, Hlavacek P.
BACKGROUND: Formularies often employ restriction policies to reduce pharmacy costs. Pregabalin, an alpha-2-delta ligand, is approved for treatment of fibromyalgia (FM); neuropathic pain (NeP) due to postherpetic neuralgia (PHN), diabetic peripheral neuropa... (Source: SafetyLit)
Source: SafetyLit - August 31, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Gabapentinoids Ineffective for Chronic Low Back Pain Gabapentinoids Ineffective for Chronic Low Back Pain
The gabapentinoids pregabalin and gabapentin are not effective in treating chronic low back pain (CLBP), according to a systematic review and meta-analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Pregabalin No Better Than Placebo in Sciatica
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - June 17, 2017 Category: Orthopaedics Tags: Trends and Innovations Source Type: news

Pregabalin Is Effective in Reducing Fibromyalgia Pain Pregabalin Is Effective in Reducing Fibromyalgia Pain
While the referenced study concluded that pregabalin is effective for fibromyalgia pain, this reviewer found defects in its assumptions and methodology, limiting its clinical relevancy.Evidence-Based Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 19, 2017 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Dangers of mixing heroin and commonly prescribed non-opioid pain killers
A multi-disciplinary study has shown that the recent substantial increase in prescriptions for two drugs, pregabalin and gabapentin, used widely for a range of neurological disorders is closely correlated with a rise in the number of overdose deaths in England and Wales. (Source: NHS Networks)
Source: NHS Networks - May 15, 2017 Category: UK Health Source Type: news

Combining heroin and commonly prescribed non-opioid pain killers leads to a significant rise in overdose deaths
A multi-disciplinary study has shown that the recent substantial increase in prescriptions for two drugs, pregabalin and gabapentin, used widely for a range of neurological disorders is closely correlated with a rise in the number of overdose deaths in England and Wales. These drugs have become drugs of abuse, according to new University of Bristol findings published in Addiction, which highlight that they are especially dangerous when used with heroin or other opioids (Source: University of Bristol news)
Source: University of Bristol news - May 11, 2017 Category: Universities & Medical Training Tags: International, Health, Research; Faculty of Health Sciences, School of Social and Community Medicine, Faculty of Health Sciences; Press Release Source Type: news

Combining heroin and commonly prescribed non-opioid pain killers leads to a significant rise in over
(University of Bristol) A multi-disciplinary study has shown that the recent substantial increase in prescriptions for two drugs, pregabalin and gabapentin, used widely for a range of neurological disorders is closely correlated with a rise in the number of overdose deaths in England and Wales. These drugs have become drugs of abuse, according to new University of Bristol findings published in Addiction, which highlight that they are especially dangerous when used with heroin or other opioids. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2017 Category: International Medicine & Public Health Source Type: news

Which Drugs Work for Diabetic Peripheral Neuropathy Pain? (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH Duloxetine, venlafaxine, pregabalin, oxcarbazepine, tricyclic antidepressants, atypical opioids (e.g., tapentadol), and botulinum toxin are all more effective than placebo in reducing … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 27, 2017 Category: Primary Care Source Type: news

No Benefit of Pregabalin in Sciatica No Benefit of Pregabalin in Sciatica
The antiepileptic/analgesic drug was no more effective than placebo in reducing leg-pain intensity in patients with moderate-to-severe sciatica in a randomized trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 23, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Common sciatica pain drug no better than placebo
New study looked at the effectiveness of Lyrica in patients with acute sciatica causing low back and leg pain (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 23, 2017 Category: Consumer Health News Source Type: news

Drug No Better Than Placebo for Lower Back, Leg Pain
Pregabalin, commonly known as Lyrica, didn't help patients with acute sciatica in study Source: HealthDay Related MedlinePlus Pages: Medicines, Sciatica (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 23, 2017 Category: Consumer Health News Source Type: news

Pregabalin No Help for Sciatica Leg Pain
(MedPage Today) -- More adverse events, mostly dizziness, for those on the drug (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 23, 2017 Category: Psychiatry Source Type: news

Pregabalin Doesn't Help Sciatica Pain (FREE)
By the Editors Pregabalin (Lyrica) doesn't seem to improve sciatica pain, according to a study in the New England Journal of … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 23, 2017 Category: Primary Care Source Type: news

Drug No Better Than Placebo for Sciatica
Pregabalin, commonly known as Lyrica, didn't help patients with acute sciatica in study (Source: WebMD Health)
Source: WebMD Health - March 22, 2017 Category: Consumer Health News Source Type: news

Pregabalin found ineffective against sciatic pain
(Reuters Health) - - Pregabalin, the pain-fighting drug better known by the Pfizer brand name Lyrica, works no better than placebo at relieving the leg pain associated with sciatica, according to results from an Australian study of more than 200 patients. (Source: Reuters: Health)
Source: Reuters: Health - March 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Millions with back pain prescribed drug that does nothing
In a study of more than 200 patients, pregabalin - originally marketed as Lyrica by pharmaceutical giant Pfizer - performed no better than a dummy pill at relieving their agony. (Source: the Mail online | Health)
Source: the Mail online | Health - March 22, 2017 Category: Consumer Health News Source Type: news

Drug No Better Than Placebo for Lower Back, Leg Pain
WEDNESDAY, March 22, 2017 -- The widely prescribed pain drug pregabalin (brand name: Lyrica) may be no better than a placebo when it comes to treating the back and leg pain known as sciatica, a new clinical trial suggests. The study, published... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 22, 2017 Category: Journals (General) Source Type: news

Epilepsy drug relieves symptoms that cause migraines
Known as Lyrica, it relieves a seizure-like phenomenon believed to be the underlying cause of the blinding headaches, according to researchers from British Columbia University, Canada. (Source: the Mail online | Health)
Source: the Mail online | Health - February 28, 2017 Category: Consumer Health News Source Type: news

Hope for migraine sufferers?
Known as Lyrica, it relieves a seizure-like phenomenon believed to be the underlying cause of the blinding headaches, according to researchers from British Columbia University, Canada. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2017 Category: Consumer Health News Source Type: news

Lyrica (Pregabalin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 3, 2017 Category: Drugs & Pharmacology Source Type: news

Preoperative Pregabalin and Postop Nausea and Vomiting Preoperative Pregabalin and Postop Nausea and Vomiting
Preoperative pregabalin has been shown to improve postoperative pain. Might it also be useful to prevent postoperative nausea and vomiting?Anesthesia & Analgesia (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 13, 2016 Category: Surgery Tags: Anesthesiology Journal Article Source Type: news

Determining the toxicological significance of pregabalin in fatalities - Elliott SP, Burke T, Smith C.
Pregabalin has become more widely prescribed and abused in recent years but is still not always included in laboratory analysis. An LC-MS-MS method has been developed and applied to measure pregabalin in 93 postmortem cases, including drug-related deaths, ... (Source: SafetyLit)
Source: SafetyLit - November 25, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Lyrica (pregabalin)
Title: Lyrica (pregabalin)Category: MedicationsCreated: 4/2/2007 12:00:00 AMLast Editorial Review: 11/4/2016 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - November 4, 2016 Category: Anesthesiology Source Type: news

Lower PNP costs with pregabalin vs gabapentin in Spain
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 31, 2016 Category: Drugs & Pharmacology Source Type: news

Preop Pregabalin Cuts Postop Nausea Preop Pregabalin Cuts Postop Nausea
As well as being opioid-sparing and curbing postoperative pain, preoperative pregabalin helps quell subsequent nausea and vomiting, according to a new meta-analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 22, 2016 Category: Surgery Tags: Anesthesiology News Source Type: news

Me vs. Fibromyalgia -- SPECIAL EDITION -- Marshall Field V: 6 Tips on Chronic Pain
Chronic Pain is brutal, unpredictable, exhausting and of course, really painful. Somedays it feels a tornado ravaged my body, leaving nothing but wreckage behind. Chronic Pain takes away my comfort. Chronic Pain takes away my energy and even my independence. But there is one thing that Chronic Pain cannot touch: my mindset. That being true, I decided years ago that keeping an optimistic, victim-free attitude would always be a top priority in my life. So when Marshall Field told me about his no excuses and no BS mentality with Chronic Pain, I felt the Fibro Warrior in me come to the front line. I closed out Part 1 with a f...
Source: Healthy Living - The Huffington Post - August 19, 2016 Category: Consumer Health News Source Type: news

Meds for Teen Fibromyalgia? Not So Fast (CME/CE)
(MedPage Today) -- Primary endpoint failed in a randomized trial of pregabalin (Source: MedPage Today Pain Management)
Source: MedPage Today Pain Management - August 12, 2016 Category: Anesthesiology Source Type: news

A decade of gabapentinoid misuse: an analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database - Chiappini S, Schifano F.
INTRODUCTION: The gabapentinoids pregabalin and gabapentin are being increasingly prescribed for a range of clinical conditions. Recently, although gabapentinoids at therapeutic dosages may present with low addictive liability levels, cases of misuse and r... (Source: SafetyLit)
Source: SafetyLit - June 28, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Pregabalin Linked to Major Birth DefectsPregabalin Linked to Major Birth Defects
Exposure to pregabalin, an antiepileptic also prescribed for pain and psychiatric disorders, during pregnancy is linked to a 3-fold increased risk for major birth defects, a new study suggests. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 24, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Maternal pregabalin exposure linked to major birth defect risk
First trimester exposure to pregabalin may be associated with an increased risk of major birth defects, an observational study suggests. (Source: MedWire News)
Source: MedWire News - May 19, 2016 Category: Consumer Health News Tags: Neurology Source Type: news

Medical News Today: Birth defect risk may increase with use of pain, anxiety drug in pregnancy
Women who take the drug pregabalin - used to treat pain, anxiety, and epilepsy - during pregnancy may be more likely to have a child with a birth defect, say researchers. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 19, 2016 Category: Consumer Health News Tags: Pregnancy / Obstetrics Source Type: news

Epilepsy Drug Lyrica Linked to Birth Defects Risk
Expectant mothers should probably avoid the drug, experts say, although study didn't prove cause and effect (Source: WebMD Health)
Source: WebMD Health - May 19, 2016 Category: Consumer Health News Source Type: news

Pain, Seizure Drug Linked to Birth Defects in Small Study (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD Maternal use of pregabalin (Lyrica) might be associated with increased risk for birth defects in offspring, according to a small case-control study in Neurology. In the U.S., pregabalin is … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 18, 2016 Category: Primary Care Source Type: news

Pain, epilepsy drug Lyrica may increase birth defects risk, study suggests
Steven Reinberg, HealthDay News The widely prescribed drug pregabalin, sold as Lyrica, may slightly increase the risk for birth defects, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 18, 2016 Category: Consumer Health News Source Type: news

Human Birth Defects Seen With Pregabalin (CME/CE)
(MedPage Today) -- Time for a pregnancy category change? (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 18, 2016 Category: Psychiatry Source Type: news

Common drug taken for anxiety, pain and epilepsy 'could cause birth defects'
Pregabalin is approved to treat epilepsy, fibromyalgia and neuropathic pain - such as pain from diabetic neuropathy or pain after shingles or spinal cord injury. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2016 Category: Consumer Health News Source Type: news

Pain, Epilepsy Drug Lyrica May Increase Birth Defects Risk, Study Suggests
Expectant mothers should probably avoid the drug, experts say, although study didn't prove cause and effect Source: HealthDay Related MedlinePlus Pages: Birth Defects, Pregnancy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 18, 2016 Category: Consumer Health News Source Type: news

Pain, Epilepsy Drug Lyrica May Increase Birth Defects Risk, Study Suggests
WEDNESDAY, May 18, 2016 -- The widely prescribed drug pregabalin (Lyrica) may slightly increase the risk for birth defects, a new study suggests. In a small study, researchers found that among women taking Lyrica during the first trimester of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2016 Category: Journals (General) Source Type: news

pregabalin, Lyrica
Title: pregabalin, LyricaCategory: MedicationsCreated: 4/2/2007 12:00:00 AMLast Editorial Review: 3/31/2016 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - March 31, 2016 Category: Anesthesiology Source Type: news

Lyrica Plus Speech Therapy May Help in Chronic Cough (CME/CE)
(MedPage Today) -- Benecial effects continued for at least 4 weeks after cessation of pregabalin (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - March 28, 2016 Category: Respiratory Medicine Source Type: news

November's top stories: Phase III trial of sirukumab, Lyrica fails trial
GlaxoSmithKline begins Phase III trial of sirukumab, Pfizer's neuropathic pain drug Lyrica fails Phase III trial, and Seattle begins Phase I/II trial of SGN-CD33A. Drugdevelopment-technology.com wraps up key headlines from November. (Source: Drug Development Technology)
Source: Drug Development Technology - December 11, 2015 Category: Pharmaceuticals Source Type: news